GenFleet Therapeutics

Innovation, in Expedition

Founded 2017 China

Shanghai, China 24 employees Series C Total: $1.02B Biotechnology, Health Care +1

GenFleet Therapeutics, with the slogan "Innovation, in Expedition," is a pioneering biotechnology startup founded in 2017 and headquartered in China. The company is dedicated to addressing significant unmet medical needs by leveraging its R&D platform based on disease biology and translational medicine. With a focus on researching the latest biological mechanisms of cancer pathways, tumor microenvironment, and human immunoregulation, GenFleet has built a rich and diversified pipeline comprising multiple cutting-edge products with novel mechanisms and global intellectual property rights. Over the years, GenFleet has established itself as a leader in developing novel drugs, encompassing both small molecules and biologics. Its cutting-edge pipeline boasts over 10 products, with three already progressing into clinical stages. As more projects advance into late-stage clinical trials, GenFleet is poised to unveil its blueprint for commercialization within the next 3-5 years. Notably, the company secured a substantial CNY500.00M Series C investment on 31 December 2021, attracting prominent investors including CDH Investments, Dyee Capital, Baidu Venture, 上海善金资产管理有限公司, ABC International, Wenzhou Dongchuang Xinhui, Qiaojing Eastern Investment, Suxin Venture Capital, and CHERAMI. With this latest investment infusion, GenFleet is well-positioned to further advance its groundbreaking research and development efforts in the biotechnology, healthcare, and pharmaceutical industries, making it a compelling prospect for venture capital consideration.

Funding Stage	Amount	Investors	Lead Investors	Date
Series C	CNY500.00M	10	CDH Investments, Dyee Capital +8	31 Dec 2021
Series B	Undisclosed	-		01 Jan 2021
Series B	CNY400.00M	-		08 Mar 2020
Series A	$17.29M	-		30 Nov 2018
Seed Round	CNY100.00M	-		30 Apr 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Series C

CNY500.00M

CDH Investments, Dyee Capital +8

31 Dec 2021

Series B

Undisclosed

01 Jan 2021

Series B

CNY400.00M

08 Mar 2020

Series A

$17.29M

30 Nov 2018

Seed Round

CNY100.00M

30 Apr 2018

FAQ About GenFleet Therapeutics

Innovation, in Expedition

GenFleet Therapeutics was founded in 2017.

GenFleet Therapeutics is headquartered in Shanghai, China.

GenFleet Therapeutics operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Biopharmaceutical, Medical Research, Translational Medicine and Cancer Biology.

GenFleet Therapeutics has approximately 24 employees.

GenFleet Therapeutics has completed 5 funding rounds, raising a total of $1.02B. The latest funding stage is Series C.

Top alternatives and competitors to GenFleet Therapeutics include Surface Oncology Inc., Apollomics, Sensei Bio, Biotecnol Limited, Sumitomo Pharma Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

GenFleet Therapeutics and Surface Oncology Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About GenFleet Therapeutics

Funding Rounds & Investors (5)

GenFleet Therapeutics Alternatives & Competitors

FAQ About GenFleet Therapeutics